Changes to Biohit Oyj’s management

Biohit Oyj August 26, 2013 at 10:30 a.m. local time (EET)

M.Sc. (Econ.) Jaana Mattila (b. 1966) has been appointed as Chief Financial Officer (CFO) and a member of the management team of Biohit Oyj starting August 26, 2013. Before Biohit she has been Finance Director at Fazer Amica Oy and worked in finance managerial positions at Stora Enso Oyj and Baxter Oy.

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission is "Innovating for Health". The purpose of the company is to take social responsibility and produce innovation, new technologies and analysis systems for use in medicine, research institutions and industry, helping to promote research and diagnostics and to improve the quality of life of people by preventing disease, human suffering and financial loss. We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in China, Italy and the United Kingdom. Since 1999, Biohit's series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector. www.biohithealthcare.com